Complementary and alternative medicine for hypertension: What evidence is there for herbalist suggestions?

Evidence-Based Integrative Medicine

Volumn 2, Issue 1, 2005, Pages 47-55

  Cicero, Arrigo F G ^a,b   Gaddi, Antonio V ^a   Borghi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ARGININE; BORAGO OFFICINALIS EXTRACT; CALCIUM; CAPTOPRIL; CRATAEGUS EXTRACT; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; FISH OIL; GAMMA LINOLENIC ACID; GARLIC EXTRACT; GRIFOLA FRONDOSA EXTRACT; HERBACEOUS AGENT; ISPAGULA; MAGNESIUM; OLEA EUROPAEA EXTRACT; OLIVE LEAF EXTRACT; POTASSIUM; PRIMROSE OIL; PYRIDOXINE; STEVIA REBAUDIANA EXTRACT; SUNFLOWER OIL; TAURINE; UBIDECARENONE; UNCLASSIFIED DRUG; UREA;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALTERNATIVE MEDICINE; ARTICLE; AWARENESS; BLEEDING; BLOATING; BLOOD PRESSURE REGULATION; BRADYCARDIA; CLINICAL TRIAL; CONSTIPATION; CONTACT DERMATITIS; COUNSELING; CRATAEGUS; DIARRHEA; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM INJURY; DRUG SAFETY; ELEUTHEROCOCCUS SENTICOSUS; EVENING PRIMROSE; FATIGUE; FLATULENCE; FREQUENCY ANALYZER; GARLIC; GASTROINTESTINAL DISEASE; HALITOSIS; HEADACHE; HEART ARRHYTHMIA; HERBAL MEDICINE; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOPHOSPHATEMIA; ITALY; MEDICAL INFORMATION; MEDICAL SOCIETY; MYALGIA; NAUSEA; NAUSEA AND VOMITING; NEUROPATHY; OLIVE; P WAVE; PHYSICIAN; PLANT LEAF; QRS COMPLEX; QT PROLONGATION; QUESTIONNAIRE; SEDATION; SENSORY NEUROPATHY; SIDE EFFECT; ST SEGMENT DEPRESSION; STEVIA; TACHYCARDIA; TASTE DISORDER; TEACHER; TRANQUILIZING ACTIVITY; VISCUM ALBUM; VOMITING;

EID: 23944457584     PISSN: 11762330     EISSN: None     Source Type: Journal    
DOI: 10.2165/01197065-200502010-00009     Document Type: Article

References (59)

1. Bean WB. Sir William Osler: aphorism from his bedside teaching and writing. Springfield (IL): Thomas, 1968
2. Capasso L. 5300 years ago, the Ice Man used natural laxatives and antibiotics. Lancet 1998; 352: 1864
3. Goldman P. Herbal medicine today and the roots of modern pharmacology. Ann Intern Med 2001; 135: 594-600
4. Rees L, Weil A. Integrated medicine. BMJ 2001; 322: 119-20
5. Austin JA. Why patients use alternative medicine. JAMA 1998; 279: 1548-53
6. Scott GN, Elmer GW. Update on natural product-drug interactions. Am J Health Syst Pharm 2002; 59 (4): 339-47
7. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002; 287 (3): 337-44
8. SPSS® , version 11.0 [computer program]. Chicago (IL): SPSS Inc.
9. Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal medicine: expanded commission E monographs. Newton (MA): Integrative Medicine Communications, 2000
10. Bruneton J. Pharmacognosie, phytochimie, plantes médicinales. Cachan: Editions Internationales Médicales, 1999
11. Barnes J, Anderson LA, Philipson JD. Herbal medicines. 2nd ed. Oxon: Pharmaceutical Press, 2002
12. Mason P. Dietary supplements. 2nd ed. Oxon: Pharmaceutical Press, 2002
13. Rapport L, Lockwood B. Nutraceuticals. Oxon: Pharmaceutical Press, 2002
14. Cherif S, Rahal N, Haouala M, et al. A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension [in French]. J Pharm Belg 1996; 51 (2): 69-71
15. Ferrara LA, Raimondi AS, d'Episcopo L, et al. Olive oil and reduced need for antihypertensive medications. Arch Intern Med 2000; 160 (6): 837-42
16. Tauchert M, Ploch M, Huebner WD. Wirksamkeit des weissdorn-extraktes LI 132 im vergleich mit Captopril. Muench Med Wochenschr 1994; 136 Suppl. 1: S27-33
17. Walker AF, Marakis G, Morris AP, et al. Promising hypotensive effect of hawthorn extract: a randomised double-blind pilot study of mild essential hypertension. Phytother Res 2002; 16 (1): 48-54
18. Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm 2002; 59 (5): 417-22
19. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994; 12 (4): 463-8
20. Steiner M, Khan AH, Holbert D, et al. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996; 64 (6): 866-70
21. O'Brien PM, Broughton Pipkin FB. The effect of essential fatty acid and specific vitamin supplements on vascular sensitivity in the mid-trimester of human pregnancy. Clin Exp Hypertens B 1983; 2 (2): 247-54
22. Barre DE. Potential of evening primrose, borage, black currant, and fungal oils in human health. Ann Nutr Metab 2001; 45 (2): 47-57
23. Hansen K, Nyman U, Smitt UW, et al. In vitro screening of traditional medicines for anti-hypertensive effect based on inhibition of the angiotensin converting enzyme (ACE). J Ethnopharmacol 1995; 48 (1): 43-51
24. Burke V, Hodgson JM, Beilin LJ, et al. Dietary proteins and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 2001; 38 (4): 821-6
25. Boeckh-Haebisch EMA. Pharmacological trial of concentrated crude extract of Stevia rebaudiana (Bert.) Bertoni in healthy volunteers. Arg Biol Technol 1992; 35 (2): 299-314
26. Chan P, Tomlinson B, Chen YJ, et al. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br J Clin Pharmacol 2000; 50 (3): 215-20
27. Mayel M. Maitake extracts and their therapeutic potential. Altern Med Rev 2001; 6 (1): 48-60
28. Witteman JCM, Grobbee DE, Derkx FHM. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60: 129-35
29. Kisters K, Spieker C, Tepel M, et al. New data about the effects of oral physiologi-cal magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 1993; 6 (4): 355-60
30. Borrello G, Curcio F, Mazza ML, et al. The effects of magnesium oxide on mild essential hypertension and quality of life. Curr Therap Res 1996; 57: 767-74
31. Yamamoto ME, Applegate WB, Klag MJ, et al. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure: results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol 1995; 5 (2): 96-107
32. Weinberger MH, Wagner UL, Fineberg NS. The blood pressure effects of calcium supplementation in humans of known sodium responsiveness. Am J Hypertens 1993; 6 (9): 799-805
33. Zemel MB. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 2001; 20 (5 Suppl.): 428S-35S
34. Bucher HC, Cook RJ, Guyatt GH, et al. Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996; 275 (13): 1016-22
35. Morikawa Y, Nakagawa H, Okayama A, et al. A cross-sectional study on associa-tion of calcium intake with blood pressure in Japanese population. J Hum Hypertens 2002; 16 (2): 105-10
36. Das UN. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot Essent Fatty Acids 2000; 63 (6): 351-62
37. Mori TA, Bao DQ, Burke V, et al. Docosahexaenoic acid, but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999; 34: 253-60
38. Sanders TAB, Hinds A. The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. Br J Nutr 1992; 68: 163-73
39. Prisco D, Paniccia R, Bandinelli B, et al. Effect of medium-term supplementation cardiovaswith a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 1998; 91: 105-12
40. Bonaa KH, Bjerve KS, Straume B, et al. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. N Engl J Med 1990; 322: 795-801
41. Chin JP, Gust AP, Nestel PJ, et al. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993; 21: 22-8
42. Leeds AR, Gray I, Ahmad MNMA. Effects of n-6 essential fatty acids as evening primrose oil in mild hypertension. In: Horrobin DF, editor. Omega-6 essential fatty acids, pathophysiology and roles in clinical medicine. New York: Alan R Liss Inc., 1990: 157-71
43. Nestel PJ, Clifton PM, Noakes M, et al. Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist: hip ratio. J Hypertens 1993; 11 (12): 1387-94
44. Greenberg S, Frishman WH. Co-enzyme Q10: a new drug for cardiovascular disease. J Clin Pharmacol 1990; 30: 596-608
45. Langsjoen P, Langsjoen P, Willis R, et al. Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med 1994; 15 Suppl.: S265-72
46. Ma A, Zhang W, Liu Z. Effect of protection and repair of mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy. Blood Press 1996; 5: 53-5
47. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebocontrolled trial of coenzyme Q10 in isolated systolic hypertension. South Med J 2001; 94 (11): 1112-7
48. Sacks FM, Willett WC, Smith A, et al. Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension 1998; 31: 131-8
49. Siani A, Strazzullo P, Russo L, et al. Controlled trial of long term oral potassium supplements in patients with mild hypertension [published erratum appears in Br Med J (Clin Res Ed) 1987; 294 (6604): 961]. Br Med J (Clin Res Ed) 1987; 294: 1453-6
50. Aybak M, Sermet A, Ayyildiz MO, et al. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hyperten-sion. Arzneimittelforschung 1995; 45 (12): 1271-3
51. Adams KE, Cohen MH, Eisenberg D, et al. Ethical considerations of complementa-ry and alternative medical therapies in conventional medical settings. Ann Intern Med 2002; 137 (8): 660-4
52. Rosano GMC, Panina G, Cerquetani E. L-arginine improves endothelial function in newly diagnosed hypertensives [abstract]. J Am Coll Cardiol 1998; 31 (2 Suppl. A): 262
53. Cheng JW, Baldwin SN, Balwin SN. L-arginine in the management of cardiovascular diseases. Ann Pharmacother 2001; 35 (6): 755-64
54. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280 (18): 1569-75
55. Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med 1998; 158 (20): 2225-34
56. Patel RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother 2002; 36 (1): 40-5
57. Gray CM, Tan AW, Pronk NP, et al. Complementary and alternative medicine use among health plan members: a cross-sectional survey. Eff Clin Pract 2002; 5 (1): 17-22
58. Eisenberg DM, Kessler RC, Van Rompay MI, et al. Perceptions about complemen-tary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001; 135 (5): 344-51
59. Owen DK, Lewith G, Stephens CR. Can doctors respond to patients' increasing interest in complementary and alternative medicine? BMJ 2001; 322: 134-8